Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
Sponsor content
359 result(s) found, displaying 281 to 290
-
Designation or determinationPriority review
-
Designation or determinationProvisional approval
-
Prescription medicine registrationActive ingredients: ertugliflozin.
-
Prescription medicine registrationActive ingredients: ertugliflozin and sitagliptin phosphate monohydrate.
-
Prescription medicine registrationActive ingredients: ertugliflozin and metformin hydrochloride.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NOXAFIL posaconazole 100mg modified release tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA XR 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg modified release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA XR 100/1000 sitagliptin(as phosphate monohydrate) 100 mg and metformin hydrochloride 1000 mg modified release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA XR 50/1000 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride1000 mg modified release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA 50/1000 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride1000 mg tablet blister pack.